ArticleCancers2020

Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.

William H Gmeiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.